Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michele Clerico
Observed names:
M Clerico,
M. Clerico
Institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
University of Turin
Observed institutions:
Université Paris Cité,
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
Assistance Publique – Hôpitaux de Paris,
Hôpital Saint-Louis,
University of Turin
ORCID:
0009-0007-3791-899X
Observed ORCID:
0009-0007-3791-899X
OpenAlex ID:
A5063921744
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
2022
·
Michele Clerico
, Irene Dogliotti
, et al.
·
Journal of Clinical Medicine
·
35
PDF
Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up
2022
·
Mattia Parisi
, Irene Dogliotti
, et al.
·
European Journal of Neurology
·
21
PDF
Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study
2024
·
Irene Dogliotti
, Veronica Peri
, et al.
·
Cancer Medicine
·
18
PDF
Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions
2023
·
Corrado Benevolo Savelli
, Michele Clerico
, et al.
·
Cancers
·
15
PDF
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma
2021
·
Elisa Genuardi
, Petra Klous
, et al.
·
Hematological Oncology
·
8
PDF
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience
2022
·
Michele Clerico
, Irene Dogliotti
, et al.
·
Journal of Personalized Medicine
·
7
PDF
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia
2021
·
Irene Dogliotti
, Simone Ragaini
, et al.
·
Journal of Personalized Medicine
·
7
PDF
Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study
2025
·
Alessia Castellino
, Lorenzo Comba
, et al.
·
Annals of Hematology
·
3
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment
2021
·
Michele Clerico
, Irene Dogliotti
, et al.
·
HemaSphere
·
3
CAR T-Cells Treatment for Relapsed/Refractory B-Cell Lymphoma Is Effective and Safe in People Living with HIV (PLWH): A Lysa Study from the Descar-T Registry
2024
·
Michele Clerico
, Axel André
, et al.
·
Blood
·
2
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial
2024
·
Michele Clerico
, Simone Ferrero
, et al.
·
Scientific Reports
·
2
Health-Related Quality of Life Profile and Symptom Burden of Patients with Aggressive B-Cell Lymphomas Just before CAR-T-Cell Therapy: A Real-World Study By the Gimema
2023
·
Fabio Efficace
, Pier Luigi Zinzani
, et al.
·
Blood
·
2
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study
2026
·
Irene Dogliotti
, Cristina Jiménez
, et al.
·
Blood Advances
·
1
Non-Hodgkin lymphoma treated with anti-CD20 antibody-based immunochemotherapy
2023
·
Michele Clerico
, Simone Ragaini
, et al.
·
Elsevier eBooks
·
1
“Green oncology”: a new paradigm for medical oncology
2015
·
G. Porcile
, E. Aitini
, et al.
·
Annals of Oncology
·
1
PDF
Immunotherapies and Chemo-Sparing Approaches: A New Era for Diffuse Large B-Cell Lymphoma in Older Patients
2026
·
Filippo Fasano
, Bianca Patarnello
, et al.
·
Cancers
Integrating new and “old” cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma
2026
·
Enrico Amaducci
, Michele Clerico
, et al.
·
Frontiers in Oncology
PDF
Occult hepatitis B virus infection status is not associated with impaired efficacy of anti‐CD19 CAR‐T‐cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART‐SIE study
2026
·
Nicola Polverelli
, Annalisa Chiappella
, et al.
·
HemaSphere
Hbc-positive status for hepatis B virus does not affect CAR-T cell outcomes in lymphoma: Results from the CART-SIE study
2025
·
Nicola Polverelli
, Annalisa Chiappella
, et al.
·
Blood
PDF
Cytomegalovirus (CMV) reactivation negatively impacts survival after CAR T-cell therapy in lymphoma patients: Results from the CART-SIE study
2025
·
Nicola Polverelli
, Annalisa Chiappella
, et al.
·
Blood
Pattern of infections and impact on immunocompetence of next generation B-cell depleting immunotherapies in non-Hodgkin's lymphomas: Results from a multicentre retrospective real- life cohort.
2025
·
Alessia Castellino
, Simone Ragaini
, et al.
·
Blood
PDF
522 | Clinical Approach and Outcome of Diffuse Large B Cell Lymphoma With Persistent Pet Positivity After Frontline Treatment: Subgroup Analysis of the Strider Study
2025
·
M. Bisio
, I. Dogliotti
, et al.
·
Hematological Oncology
PDF
277 | Prephase Treatment With Vitamin D Supplementation in Older Patients With Diffuse Large B‐cell Lymphoma: a Randomized Trial by Fondazione Italiana Linfomi
2025
·
F. Merli
, T. Lazic
, et al.
·
Hematological Oncology
PDF
314 | Isolated Central Nervous System Relapse After Car‐t Cell Infusion in Large B‐cell Lymphomas: an Analysis From the Italian Cart‐sie Study
2025
·
A. Chiappella
, A. Barone
, et al.
·
Hematological Oncology
PDF
Correction to: Anti CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the RFolSTOP multicentre Italian study
2025
·
Alessia Castellino
, Lorenzo Comba
, et al.
·
Annals of Hematology
PDF
Show more works
View as search
Works count:
39
Citation count:
126
H-index:
7
I10-index:
4
Year
Topic
Type